skip to main content
Idioma:
Refinado por: idioma: Alemão remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS)± long-acting β2-agonist (LABA): a randomized, double-blind, placebo-controlled study
Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS)± long-acting β2-agonist (LABA): a randomized, double-blind, placebo-controlled study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS)± long-acting β2-agonist (LABA): a randomized, double-blind, placebo-controlled study

Schmidt, O ; Ohta, K ; Ichinose, M ; Tohda, Y ; Engel, M ; Moroni-Zentgraf, P ; Kunimitsu, S ; Sakamoto, W ; Adachi, M

Pneumologie, 2015, Vol.69 (S 01) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
2
Once-daily tiotropium Respimat add-on to ICS ± LABA improves control across asthma severities
Once-daily tiotropium Respimat add-on to ICS ± LABA improves control across asthma severities
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Once-daily tiotropium Respimat add-on to ICS ± LABA improves control across asthma severities

Schmidt, O ; FitzGerald, JM ; Kerstjens, H ; Paggiaro, P ; Ohta, K ; Ichinose, M ; Moroni-Zentgraf, P ; Engel, M ; Schmidt, H ; Bateman, E

Pneumologie, 2015, Vol.69 (S 01) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.